Nifty
Sensex
:
:
13967.50
47409.93
-271.40 (-1.91%)
-937.66 (-1.94%)

Pharmaceuticals & Drugs - Domestic

Rating :
74/99  (View)

BSE: 506820 | NSE: ASTRAZEN

3757.75
165.95 (4.62%)
27-Jan-2021 | 3:58PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  3552.30
  •  3863.00
  •  3540.00
  •  3591.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  279734
  •  10511.70
  •  4970.00
  •  1885.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,988.75
  • 110.63
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,736.23
  • 0.03%
  • 22.19

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 1.52%
  • 18.30%
  • FII
  • DII
  • Others
  • 2.36%
  • 1.39%
  • 1.43%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.43
  • 8.09
  • 13.36

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.52
  • 49.03
  • 21.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.19
  • 68.86
  • 40.73

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 89.61
  • 115.50
  • 118.37

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.65
  • 23.65
  • 23.65

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 47.05
  • 61.52
  • 61.81

Quarterly Results

Standalone Figures in Rs. Crores

Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:


News Update


  • AstraZeneca Pharma gets import, market permission for Benralizumab solution for injection
    21st Dec 2020, 09:41 AM

    The receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt of related statutory approvals and licenses

    Read More
  • Astrazeneca Pharma I - Quarterly Results
    5th Nov 2020, 16:10 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.